Clinical Trials Browser

Phase NA × pyrotinib × Gastrointestinal × Clear all

NCT03843749 2019-02-18

Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.

Phase NA Unknown

Gastrointestinal

Colorectal Neoplasms